{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:31:52Z","timestamp":1760189512943},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejso.2016.07.137","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T18:38:31Z","timestamp":1470508711000},"page":"1471-1477","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance"],"prefix":"10.1016","volume":"42","author":[{"given":"C.","family":"Mosquera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"Koutlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.L.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejso.2016.07.137_bib1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A\u00a05-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2016.07.137_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"18","key":"10.1016\/j.ejso.2016.07.137_bib3","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2016.07.137_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.surg.2015.03.042","article-title":"Increasing incidence of duodenal neuroendocrine tumors: incidental discovery of indolent disease?","volume":"158","author":"Fitzgerald","year":"2015","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.ejso.2016.07.137_bib5","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/ERC-13-0125","article-title":"Knowledge NETwork. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","volume":"21","author":"Fraenkel","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"18","key":"10.1016\/j.ejso.2016.07.137_bib6","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/cncr.28721","article-title":"Gastroenteropancreatic high-grade neuroendocrine carcinoma","volume":"120","author":"Sorbye","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2016.07.137_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2016.07.137_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2016.07.137_bib9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000658-199906000-00008","article-title":"Prognosis and survival in patients with gastrointestinal tract carcinoid tumors","volume":"229","author":"Shebani","year":"1999","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2016.07.137_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2016.07.137_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1196\/annals.1294.025","article-title":"Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center","volume":"1014","author":"Pape","year":"2004","journal-title":"Ann N. Y Acad Sci"},{"issue":"5","key":"10.1016\/j.ejso.2016.07.137_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.endonu.2013.12.001","article-title":"Gastroenteropancreatic neuroendocrine tumors: clinical characteristics, diagnosis and prognosis at hospital universitario clinico san carlos (madrid)","volume":"61","author":"de Miguel Novoa","year":"2014","journal-title":"Endocrinol Nutr"},{"issue":"7","key":"10.1016\/j.ejso.2016.07.137_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/02841860310010547","article-title":"Carcinoid\u2013a comprehensive review","volume":"42","author":"Schnirer","year":"2003","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.07.137_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00423-011-0741-7","article-title":"Surgical treatment of gastrointestinal neuroendocrine tumors","volume":"396","author":"Fendrich","year":"2011","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"10.1016\/j.ejso.2016.07.137_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12020-011-9562-2","article-title":"Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy","volume":"41","author":"Alexandraki","year":"2012","journal-title":"Endocrine"},{"issue":"Suppl. 1","key":"10.1016\/j.ejso.2016.07.137_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0959-8049(09)70039-5","article-title":"Surgical aspects of neuroendocrine tumours","volume":"45","author":"Akerstrom","year":"2009","journal-title":"Eur J Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.ejso.2016.07.137_bib17","doi-asserted-by":"crossref","first-page":"v223","DOI":"10.1093\/annonc\/mdq192","article-title":"Neuroendocrine gastroenteropancreatic tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Oberg","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.07.137_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ctrv.2012.06.009","article-title":"Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view","volume":"39","author":"Fazio","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ejso.2016.07.137_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.seminoncol.2012.11.011","article-title":"The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas","volume":"40","author":"Smith","year":"2013","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2016.07.137_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","article-title":"The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas","volume":"39","author":"Strosberg","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.ejso.2016.07.137_bib21","unstructured":"National Comprehensive Cancer Network. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf. Updated 11\/11\/14. [accessed 11.09.15], 2015."},{"key":"10.1016\/j.ejso.2016.07.137_bib22","unstructured":"Surveillance Research Program. http:\/\/seer.cancer.gov\/. Updated 2015. [accessed 11.09.15], 2015."},{"issue":"8","key":"10.1016\/j.ejso.2016.07.137_bib23","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.ejca.2012.12.022","article-title":"Incidence and survival of neuroendocrine tumours in The Netherlands according to histological grade: experience of two decades of cancer registry","volume":"49","author":"Korse","year":"2013","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2016.07.137_bib24","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/ijc.24698","article-title":"European disparities in malignant digestive endocrine tumours survival","volume":"126","author":"Lepage","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2016.07.137_bib25","series-title":"Gastroenteropancreatic well-differentiated Grade 3 neuroendocrine tumors: review and position statement","author":"Coriat","year":"2016"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316308071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316308071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T19:16:13Z","timestamp":1718738173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316308071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0748798316308071"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.07.137","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.07.137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}